Jazz Pharmaceuticals (JAZZ) Other financing activities (2012 - 2016)
Jazz Pharmaceuticals (JAZZ) recorded quarterly Other financing activities of -$3.5 million in Q3 2016, up 21.01% quarter-over-quarter from -$4.4 million in Q2 2016, and down 994.69% on a YoY basis from $391533.4 in Q4 2015.
Jazz Pharmaceuticals (JAZZ) Other financing activities (2012 - 2016) Analysis & Trends
Jazz Pharmaceuticals' Other financing activities history runs 5 years deep, the most recent figure standing at -$3.5 million for Q3 2016.
- In Q3 2016, Other financing activities fell 994.69% year-over-year to -$3.5 million; the TTM figure through Sep 2016 stood at $320000.0 (up 112.53% YoY), while the FY2014 annual figure was $1.8 million, changed N/A from the prior year.
- Other financing activities was -$3.5 million for Q3 2016 at Jazz Pharmaceuticals, up from -$4.4 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $10.6 million in Q1 2015 to a low of -$10.6 million in Q2 2015.
- Historically, Other financing activities has averaged $741000.0 across 5 years, with a median of $320000.0 in 2015.
- The sharpest annual moves came in 2014 and 2016: Other financing activities surged 3903.66% in 2014, then slumped 994.69% in 2016.
- A 5-year view of Other financing activities shows it stood at $5.5 million in 2012, then tumbled by 98.51% to $82000.0 in 2013, then tumbled by 2824.39% to -$2.2 million in 2014, then soared by 114.32% to $320000.0 in 2015, then slumped by 1194.69% to -$3.5 million in 2016.
- The last three Other financing activities figures came in at -$3.5 million (Q3 2016), -$4.4 million (Q2 2016), and $7.9 million (Q1 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Jazz Pharmaceuticals | 13.91 Bn | 12.06 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | -3.50 Mn |
| Sep 30, 2016 | -3.50 Mn |
| Jun 30, 2016 | -4.44 Mn |
| Jun 30, 2016 | -4.44 Mn |
| Mar 31, 2016 | 7.94 Mn |
| Mar 31, 2016 | 7.94 Mn |
| Dec 31, 2015 | 320,000.00 |
| Dec 31, 2015 | 320,000.00 |
| Sep 30, 2015 | -320,000.00 |
| Sep 30, 2015 | -320,000.00 |
| Jun 30, 2015 | -10.64 Mn |
| Jun 30, 2015 | -10.64 Mn |
| Mar 31, 2015 | 10.64 Mn |
| Mar 31, 2015 | 10.64 Mn |
| Dec 31, 2014 | -2.23 Mn |
| Dec 31, 2014 | -2.23 Mn |
| Sep 30, 2014 | 3.28 Mn |
| Sep 30, 2014 | 3.28 Mn |
| Jun 30, 2014 | -4.99 Mn |
| Jun 30, 2014 | -4.99 Mn |